Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Embecta (EMBC) Asset Writedowns and Impairment (2020 - 2026)

Embecta recorded quarterly Asset Writedowns and Impairment of $500000.0 in Q1 2026, up 104.72% quarter-over-quarter from -$10.6 million in Q3 2025.

Embecta's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $500000.0 for Q1 2026.

  • In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $500000.0; the TTM figure through Mar 2026 stood at -$9.9 million (down 195.19% YoY), while the FY2023 annual figure was $2.5 million, down 95.76% from the prior year.
  • Asset Writedowns and Impairment came in at $500000.0 for Q1 2026 at Embecta, up from -$10.6 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $58.9 million in Q3 2022 to a low of -$10.6 million in Q3 2025.
  • A 4-year average of $11.9 million and a median of $500000.0 in 2026 frame the typical range for Asset Writedowns and Impairment.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Embecta 197.17 Mn 3.77 Mn 127.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 500,000.00
Mar 31, 2026 500,000.00
Sep 30, 2025 -10.60 Mn
Sep 30, 2025 -10.60 Mn
Jun 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Dec 31, 2024 10.40 Mn
Dec 31, 2024 10.40 Mn
Sep 30, 2022 58.90 Mn
Sep 30, 2022 58.90 Mn
Jun 30, 2021 3.80 Mn
Jun 30, 2021 3.80 Mn
Dec 31, 2020 10.00 Mn
Dec 31, 2020 10.00 Mn